Position in BBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$209,784
-$578,063 QoQ
Shares Held
2,825
-72.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kovack Advisors, Inc. holds $5,306,795 across 13 Biotechnology names. BBIO ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
175,232 | $1,633,162 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,286 | $1,467,330 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
741 | $572,526 | |
| 4 | MRNA |
Moderna, Inc.
|
10,380 | $527,304 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,886 | $232,427 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
2,825 | $209,784 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,104 | $208,711 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
22,208 | $170,335 |
All Filings in BBIO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $209,784 | 2,825 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $787,847 | 10,300 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||